The Good & The Bad, AI Holy Grail, Addressing America’s Cancer Drug Shortage 6/2/23
This morning’s jobs report had something for the hawks and the doves. We’ll debate the best move for the Fed and investors’ best move in the market. Plus, our guest says there’s a “holy grail” setup in the AI space. She’ll tell us what it is and how she’s playing it. And the CEO of Bristol-Myers Squibb joins Kelly as the ASCO conference kicks off. How are they helping solve America’s cancer drug shortage? He’ll explain.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This morning’s jobs report had something for the hawks and the doves. We’ll debate the best move for the Fed and investors’ best move in the market. Plus, our guest says there’s a “holy grail” setup in the AI space. She’ll tell us what it is and how she’s playing it. And the CEO of Bristol-Myers Squibb joins Kelly as the ASCO conference kicks off. How are they helping solve America’s cancer drug shortage? He’ll explain.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.